Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$31.5 - $42.5 $567,000 - $765,000
-18,000 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$25.01 - $40.24 $48,219 - $77,582
-1,928 Reduced 9.67%
18,000 $617,000
Q4 2020

Feb 02, 2021

BUY
$28.66 - $46.79 $43,792 - $71,495
1,528 Added 8.3%
19,928 $726,000
Q3 2020

Nov 05, 2020

BUY
$14.71 - $50.69 $270,664 - $932,696
18,400 New
18,400 $893,000

Others Institutions Holding FBRX

# of Institutions
1
Shares Held
175K
Call Options Held
0
Put Options Held
0

About Forte Biosciences, Inc.


  • Ticker FBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,340,300
  • Market Cap $114M
  • Description
  • Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
More about FBRX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.